相关实验视频
Updated: Jul 23, 2025

06:47
Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
956
铁罗菲班诱导的血小板缺血
1Department of Pharmacy, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, China.
Annals of medicine
|July 13, 2023
概括
铁洛非班是一种糖蛋白IIb/IIIa抑制剂,可以防止急性冠状动脉综合征的血小板聚合. 然而,它可能会导致免疫介导的血小板缺血,这是一个令人担忧的副作用,需要仔细管理和风险因素评估.
科学领域:
- 心血管药理学心血管药理学
- 血液学 血液学 血液学
背景情况:
- 蒂罗菲班是一种糖蛋白 (GP) IIb/IIIa抑制剂,用于预防非ST段升高急性冠状动脉综合征 (NSTE-ACS) 的血栓事件.
- 虽然有效,但蒂罗菲班与血小板缺血有关,这是一个显著的不良反应.
研究的目的:
- 审查铁奥菲班诱导的血小板缩的病理生理学,临床表现,管理和危险因素.
- 为了提高人们对这种不良影响的认识,鉴于tirofiban在心血管护理中的常见用途.
主要方法:
- 关于铁奥菲班和血小板衰减的病例报告和临床试验的文献综述.
- 对拟议的免疫介导机制的分析.
主要成果:
- 蒂罗菲班诱导的血小板缺血是一种免疫媒介的不良反应.
- 了解它的发病,表现和风险因素对于患者的安全至关重要.
结论:
- 在NSTE-ACS患者中,铁洛非班诱导的血小板缩是一个严重的问题.
- 对其机制的进一步研究和改进的管理策略是有必要的.
相关概念视频
Venous Thrombosis III: Interprofessional Care
10
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
10
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
566
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
566
Anticoagulant Drugs: Low-Molecular-Weight Heparins
763
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
763
Clot Retraction and Fibrinolysis
6.5K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.5K
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.2K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.2K
Intracellular Signaling Affects Focal Adhesions
2.7K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.7K

